Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices 88777 

scenarios to complete the forms and 

then document time to complete the 

form in order to calculate burden time 

averages: the environmental form 

averaged 10 minutes, the human form 

eight minutes, and the animal form five 

minutes. Actual response times may 

vary based on the number of cases 

associated with an event. Based on these 

figures, the total estimated annualized 

burden is 73 hours, and there is no cost 

to respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

State/Territory ................ One Health Harmful Algal Bloom System 

(OHHABS) Environmental Form.

300 1 10/60 50 

State/Territory ................ One Health Harmful Algal Bloom System 

(OHHABS) Human Form.

90 1 8/60 12 

State/Territory ................ One Health Harmful Algal Bloom System 

(OHHABS) Animal Form.

130 1 5/60 11 

Total ....................... .............................................................................. ........................ ........................ ........................ 73 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–25988 Filed 11–7–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Meeting of the Advisory Board on 

Radiation and Worker Health, National 

Institute for Occupational Safety and 

Health 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

Centers for Disease Control and 

Prevention (CDC) announces the 

following meeting of the Advisory 

Board on Radiation and Worker Health 

(ABRWH or the Advisory Board). This 

is a virtual meeting. It is open to the 

public, with a public comment period. 

The public is also welcome to submit 

written comments in advance of the 

meeting, to the contact person listed in 

the addresses section below. The public 

is also welcomed to listen to the 

meeting by joining the teleconference 

(information below), limited only by the 

number of audio conference lines 

available (150). 

DATES: The meeting will be held on 

December 5, 2024, from 10 a.m. to 6 

p.m., EST. A public comment session 

will be held on December 5, 2024, at 5 

p.m., EST, and will conclude at 6 p.m., 

EST, or following the final call for 

public comment, whichever comes first. 

Written comments must be received 

on or before November 28, 2024. 

ADDRESSES: You may submit comments 

by mail to: Rashaun Roberts, National 

Institute for Occupational Safety and 

Health, 1090 Tusculum Avenue, 

Mailstop C–24, Cincinnati, Ohio 45226. 

Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 

5252 US (San Jose); and +1 646 828 

7666 US (New York). The meeting ID is: 

160 6763 3819; the Passcode is: 

98685439; and the Web conference by 

Zoom meeting connection is: https://

cdc.zoomgov.com/j/ 

16067633819?pwd=RUdiYXlZZHFK

anpJOHZrcGJIbTlaZz09

amp;omn=1602240447. 

FOR FURTHER INFORMATION CONTACT: 

Rashaun Roberts, Ph.D., Designated 

Federal Officer, National Institute for 

Occupational Safety & Health, Centers 

for Disease Control and Prevention, 

1090 Tusculum Avenue, Mailstop C–24, 

Cincinnati, Ohio 45226, Telephone: 

(513) 533–6800; Toll Free 1(800) 232– 

4636; Email: ocas@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines, that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule, advice on 

methods of dose reconstruction which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program, and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). In 

December 2000, the President delegated 

responsibility for funding, staffing, and 

operating the Advisory Board to HHS, 

which subsequently delegated this 

authority to the CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and rechartered under Executive Order 

13179 on March 22, 2024. Unless 

continued by the President the Board 

will terminate on September 30, 2025, 

consistent with E.O. 14109 of September 

29, 2023. 

Purpose: This Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advising the Secretary 

on whether there is a class of employees 

at any Department of Energy (DOE) 

facility who were exposed to radiation 

but for whom it is not feasible to 

estimate their radiation dose, and on 

whether there is reasonable likelihood 

that such radiation doses may have 

endangered the health of members of 

this class. 

Matters to be Considered: The agenda 

will include discussions on the 

following: National Institute for 

Occupational Safety & Health Program 

Update; Department of Labor Program 

Update; Department of Energy Program 

Update; SEC Petitions Status Update; 


ddrumheller on DSK120RN23PROD with NOTICES1
88778 Federal Register / Vol. 89, No. 217 / Friday, November 8, 2024 / Notices 

Procedures Review Finalization/ 

Document Approvals; Savannah River 

Site Workgroup update, Lawrence 

Livermore National Lab Addendum, and 

a Board Work Session. Agenda items are 

subject to change as priorities dictate. 

For additional information, please 

contact Toll Free 1–800–232–4636. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–26007 Filed 11–7–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–24FI] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled 

‘‘Comprehensive Evaluations for the 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation Program (WISEWOMAN), The 

National Cardiovascular Health Program 

(The National CVH Program), and The 

Innovative Cardiovascular Health 

Program (The Innovative CVH 

Program)’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on 5/7/2024 

to obtain comments from the public and 

affected agencies. CDC did not receive 

comments related to the previous 

notice. This notice serves to allow an 

additional 30 days for public and 

affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Comprehensive Evaluations for the 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation Program (WISEWOMAN), The 

National Cardiovascular Health Program 

(The National CVH Program), and The 

Innovative Cardiovascular Health 

Program (The Innovative CVH 

Program)—New—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC) Division for Heart 

Disease and Stroke Prevention (DHDSP) 

are submitting this new three-year 

information collection request (ICR) for 

an evaluation of the three recently 

launched cooperative agreements: WellIntegrated Screening of Women Across 

the Nation (WISEWOMAN), The 

National Cardiovascular Health Program 

(The National CVH Program), and The 

Innovative Cardiovascular Health 

Program (The Innovative CVH Program). 

The WISEWOMAN program supports 

the early detection and treatment of 

hypertension in low-income, uninsured, 

and underinsured participants, ages 35– 

64. The National CVH Program 

implements evidence-based strategies to 

manage CVD in populations impacted 

by the high prevalence of CVD, 

exacerbated by health inequities and 

disparities, social determinants, such as 

low incomes, poor health care, and 

unfair opportunity structures, 

emphasizing hypertension and high 

cholesterol control among adults aged 

18–85. The Innovative CVH Program 

focuses on implementing innovative 

evidence-based strategies assess and 

address the disparities and inequities in 

communities at highest risk, where 

there is a particular need for equityfocused health system interventions to 

prevent, detect, control, and manage 

hypertension and high cholesterol, 

specifically among populations with a 

crude hypertension prevalence rate of 

53% or higher at the census tract level. 

For two of the cooperative agreements, 

recipients collaborate with public health 

entities, health systems, health care 

providers, community leaders, and 

other partners through Learning 

Collaboratives to facilitate sustainable 

change and improvement in 

cardiovascular health outcomes, 

particularly for those at the highest risk 

of poorer health outcomes. These 

cooperative agreements build upon 

CDC’s previous work of identify 

promising CVD prevention and 

management practices and funding 

various organizations, including State 

and County governments, American 

Indian or Alaska Native tribal 

governments, non-government 

organizations, institutions of higher 

education, to implement evidence-based 

strategies in their jurisdictions. Since 

the cooperative agreements are a 

substantial investment of federal funds, 

it is important to demonstrate the types 

of interventions being implemented and 

what is being accomplished using these 

funds through a comprehensive 

evaluation. 

The comprehensive evaluation of 

these programs includes process and 

outcome evaluations, and a crossprogram analysis to assess the unique 

contributions of each program towards 

evidence-based strategies, health equity 

advancement, and health system 

transformation over the five program 


ddrumheller on DSK120RN23PROD with NOTICES1